Kenneth S. Cohen to Translocation, Genetic
This is a "connection" page, showing publications Kenneth S. Cohen has written about Translocation, Genetic.
Connection Strength
0.058
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.037
-
The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma. Blood Cells Mol Dis. 2010 Dec 15; 45(4):317-23.
Score: 0.021